EPAM Systems, Inc. 2024 Q2 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. EPAM Systems, Inc. is a leading global provider of digital engineering, cloud, and AI-enabled transformation services. The company operates primarily through two reportable segments: North America and Europe. The Russia segment was divested in July 2023 and is no longer reported. The company continues to manage operations impacted by the war in Ukraine, maintaining a $100 million humanitarian commitment and executing business continuity plans.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenues | $1.147 billion | $1.170 billion | $2.312 billion | $2.381 billion |
| Net Income | $98.6 million | $120.0 million | $214.9 million | $222.3 million |
| Diluted EPS | $1.70 | $2.03 | $3.67 | $3.75 |
| Operating Margin | 10.5% | 12.3% | 10.0% | 11.1% |
| Cash from Operations (YTD) | $186.9 million (2024) vs $176.4 million (2023) | |||
| Cash & Equivalents | $1.787 billion (as of June 30, 2024) | |||
| Long-Term Debt | $25.5 million (as of June 30, 2024) | |||
| Available Credit Facility | $675.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Q2 2024 revenues decreased 2.0% year-over-year, and YTD revenues decreased 2.9%. This was driven by uneven client demand, the exit from the Russia market, and unfavorable foreign currency fluctuations (which reduced revenue growth by 0.3% in Q2).
- Margin Compression: Operating margins declined to 10.5% in Q2 (from 12.3% in Q2 2023) and 10.0% YTD (from 11.1% YTD 2023). This was primarily due to increased compensation costs, including stock-based compensation and severance expenses related to cost optimization programs.
- Cost Optimization: The company initiated a 2024 Cost Optimization Program in Q2, incurring $9.2 million in employee separation costs for the quarter. Total expected charges for this program are approximately $20.0 million.
- Segment Performance:
- North America: Revenues increased 2.7% QoQ, but operating profit declined 6.7% due to higher variable compensation and FX impacts.
- Europe: Revenues decreased 7.3% QoQ, and operating profit declined 15.8%. Declines were driven by reduced spending at large accounts and FX headwinds.
- Acquisitions: Completed three acquisitions in the first half of 2024 for a total purchase price of $74.2 million, expanding capabilities in Life Sciences analytics and geographical reach in Latin America and Europe.
Guidance, Outlook, and Risks
- Outlook: Management notes that business continues to be disrupted by the war in Ukraine and uneven demand. No specific numerical guidance for the full year was provided in this text, but management expects some humanitarian and repositioning expenses to continue in future quarters.
- Share Repurchases: The company exhausted its $500 million 2023 repurchase program by June 30, 2024. On August 1, 2024, the Board authorized a new $500 million repurchase program.
- Geopolitical Risks: Significant risks remain regarding the war in Ukraine and sanctions on Belarus. Belarus instituted new restrictions in April 2024 on distributing dividends to shareholders in certain countries (including the U.S.) until the end of 2025. The company holds $80.6 million in cash in Ukraine and $38.2 million in Belarus.
- Humanitarian Commitment: As of June 30, 2024, $31.8 million remains to be expensed under the $100 million humanitarian commitment for Ukraine.
Investor Verification Checklist
- Verify the impact of the new Belarus dividend restrictions on future cash repatriation and liquidity.
- Monitor the execution and cost realization of the 2024 Cost Optimization Program (expected $20M total charges).
- Assess the sustainability of revenue growth in the North America segment given the decline in the Software & Hi-Tech and Financial Services verticals.
- Review the status of the $31.8 million remaining humanitarian commitment and potential for additional unforeseen costs related to the Ukraine conflict.
- Track the utilization of the new $500 million share repurchase program authorized in August 2024.